Optical coherence tomography in coronary atherosclerosis assessment and intervention

M Araki, SJ Park, HL Dauerman, S Uemura… - Nature Reviews …, 2022 - nature.com
Since optical coherence tomography (OCT) was first performed in humans two decades ago,
this imaging modality has been widely adopted in research on coronary atherosclerosis and …

Coronary In-Stent Restenosis: JACC State-of-the-Art Review

G Giustino, A Colombo, A Camaj, K Yasumura… - Journal of the American …, 2022 - jacc.org
The introduction and subsequent iterations of drug-eluting stent technologies have
substantially improved the efficacy and safety of percutaneous coronary interventions …

Management of in-stent restenosis

F Alfonso, JJ Coughlan, D Giacoppo… - …, 2022 - pmc.ncbi.nlm.nih.gov
In-stent restenosis (ISR) remains the most common cause of stent failure after percutaneous
coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI …

Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014

RA Byrne, M Joner, A Kastrati - European heart journal, 2015 - academic.oup.com
Modern-day stenting procedures leverage advances in pharmacotherapy and device
innovation. Patients treated with contemporary antiplatelet agents, peri-procedural …

In-stent neoatherosclerosis: a final common pathway of late stent failure

SJ Park, SJ Kang, R Virmani, M Nakano… - Journal of the American …, 2012 - jacc.org
Percutaneous coronary intervention with stenting is the most widely performed procedure for
the treatment of symptomatic coronary disease, and drug-eluting stents (DES) have …

Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug–eluting stent implantation

SJ Kang, GS Mintz, T Akasaka, DW Park, JY Lee… - Circulation, 2011 - ahajournals.org
Background—We report findings from optical coherence tomography (OCT) of in-stent
neoatherosclerosis as a cause of drug-eluting stent (DES) failure. Methods and Results …

[PDF][PDF] SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease

RF Riley, TD Henry, E Mahmud… - Catheter …, 2020 - studioyszimg.yxj.org.cn
I. Introduction The anatomic and clinical complexity of patients with coronary artery disease
(CAD) is increasing in the United States. 1–3 While the terms “complex CAD” or “high-risk …

[HTML][HTML] In stent neo-atherosclerosis: pathophysiology, clinical implications, prevention, and therapeutic approaches

A Nusca, MM Viscusi, F Piccirillo, A De Filippis… - Life, 2022 - mdpi.com
Despite the dramatic improvements of revascularization therapies occurring in the past
decades, a relevant percentage of patients treated with percutaneous coronary intervention …

Treatment of coronary in-stent restenosis: a systematic review

L Pleva, P Kukla, O Hlinomaz - Journal of geriatric cardiology …, 2018 - pmc.ncbi.nlm.nih.gov
Coronary stent implantation has significantly improved percutaneous coronary intervention
and enabled the management of early complications of plain balloon angioplasty. However …

[HTML][HTML] SCAI expert consensus statement on management of in-stent restenosis and stent thrombosis

LW Klein, S Nathan, A Maehara, J Messenger… - Journal of the Society for …, 2023 - Elsevier
Stent failure remains the major drawback to the use of coronary stents as a revascularization
strategy. Recent advances in imaging have substantially improved our understanding of the …